Skip to main content

Table 1 Demographic and general laboratory blood parameters

From: Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial

Parameter Control Dapagliflozin 10 mg P-value
Before After Con vs Bef Bef vs Aft
Age (years) 41.71 ± 6.96 54.00 ± 9.61 0.011
Men, n (%) 4 (57.14) 5 (62.5) 0.833
Weight (kg) 71.57 ± 16.15 83 ± 9.46 66.76 ± 9.79 0.674 0.360
BMI (kg/m2) 25.16 ± 3.56 27.10 ± 2.49 0.549
Waist circumference (cm) 87.86 ± 12.14 100.00 ± 7.33 0.624
AUCGlu (mmol/L·h) 20.02 ± 4.15 46.73 ± 7.49 42.66 ± 7.45  < 0.001 0.066
HbA1c (%) 5.43 ± 0.23 7.54 ± 1.42 0.002
FBG (mmol/L) 5.03 ± 0.55 7.43 ± 1.58 7.43 ± 0.97 0.005 1.000
FINS (μIU/mL) 9.75 ± 5.05 11.10 ± 4.26 11.49 ± 4.10 0.387 0.468
SUA (μmol/L) 283.57 ± 99.93 347.75 ± 32.53 273.25 ± 43.18 0.175 0.001
TC (mmol/L) 4.98 ± 0.57 5.35 ± 0.83 5.34 ± 0.90 0.376 0.947
TG (mmol/L) 1.69 ± 0.87 2.10 ± 0.98 1.71 ± 0.74 0.441 0.135
HDL-c (mmol/L) 1.36 ± 0.44 1.05 ± 0.13 1.09 ± 0.16 0.144 0.191
LDL-c (mmol/L) 3.04 ± 0.51 3.57 ± 0.79 3.72 ± 1.01 0.186 0.282
  1. Con, control; Bef, before; Aft, after; BMI, body mass index; AUC, area under the curve; Glu, glucose; HbA1c, glycated hemoglobin; FBG, fasting blood glucose; FINS, fasting serum insulin; SUA, serum uric acid; TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol